Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics.
Goure WF, Krafft GA, Jerecic J, Hefti F. Goure WF, et al. Alzheimers Res Ther. 2014 Jul 9;6(4):42. doi: 10.1186/alzrt272. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25045405 Free PMC article. Review.
Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.
Look GC, Jerecic J, Cherbavaz DB, Pray TR, Breach JC, Crosier WJ, Igoudin L, Hironaka CM, Lowe RM, McEntee M, Ruslim-Litrus L, Wu HM, Zhang S, Catalano SM, Goure WF, Summa D, Krafft GA. Look GC, et al. Among authors: goure wf. Curr Alzheimer Res. 2007 Dec;4(5):562-7. doi: 10.2174/156720507783018271. Curr Alzheimer Res. 2007. PMID: 18220523 Review.
The case for soluble Aβ oligomers as a drug target in Alzheimer's disease.
Hefti F, Goure WF, Jerecic J, Iverson KS, Walicke PA, Krafft GA. Hefti F, et al. Among authors: goure wf. Trends Pharmacol Sci. 2013 May;34(5):261-6. doi: 10.1016/j.tips.2013.03.002. Epub 2013 Apr 10. Trends Pharmacol Sci. 2013. PMID: 23582316
Feedback